Thomas Gallagher

Title: Thomas Gallagher: Innovator in Antibody Development

Introduction

Thomas Gallagher is a prominent inventor based in Cambridge, GB. He has made significant contributions to the field of biotechnology, particularly in the development of innovative antibodies. With a total of seven patents to his name, Gallagher's work focuses on advancing therapeutic options for various medical conditions.

Latest Patents

Gallagher's latest patents include groundbreaking inventions related to anti-PD-L1 antibodies. These inventions encompass bispecific antibodies that contain one domain with specificity to PD-L1, as well as immunocytokines that fuse an anti-PD-L1 antibody with a cytokine, such as IL-2. The patents also provide methods of treatment, uses, and pharmaceutical compositions that incorporate these antibodies, bispecific antibodies, and immunocytokines.

Career Highlights

Throughout his career, Gallagher has been associated with Kymab Limited, a company known for its innovative approaches in the field of immunotherapy. His work has not only contributed to the scientific community but has also paved the way for new treatment options for patients.

Collaborations

Gallagher has collaborated with notable colleagues, including Jamie Iain Campbell and Stephen D Gillies. These partnerships have further enhanced the research and development efforts within the company.

Conclusion

Thomas Gallagher's contributions to the field of antibody development exemplify the impact of innovation in biotechnology. His patents and collaborative efforts continue to shape the future of medical treatments.